Atlas Trials

MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates

Clinical trial NCT06018012 · COMPLETED

Trial details

NCT number
NCT06018012
Sponsor
Tanta University
Status
COMPLETED
Study type
OBSERVATIONAL
Neonatal Hyperbilirubinemia
Start date
2019-03-01
Primary completion
2021-03-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.